a public good project by the
Synthesis
Company
of California

© 2026

Thiess Lorenz | doi.page

0 works0 citations0 h-index

Thiess Lorenz

Universität Hamburg(DE)University Medical Center Hamburg-Eppendorf(DE)German Centre for Cardiovascular Research(DE)

Publications by Year

Research Areas

Lipoproteins and Cardiovascular Health, Acute Myocardial Infarction Research, Cardiac Imaging and Diagnostics, Coronary Interventions and Diagnostics, Pharmaceutical Economics and Policy

Most-Cited Works

→ SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe(2021)1,513 cited
→ Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium(2019)284 cited
→ Prognostic Value of Cardiovascular Biomarkers in the Population(2024)93 cited
→ Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population(2019)54 cited
→ Association between outdoor artificial light at night and sleep duration among older adults in China: A cross-sectional study(2022)48 cited
→ Personalized diagnosis in suspected myocardial infarction(2023)31 cited

→ Association of High‐Sensitivity Troponin T and I Blood Concentrations With All‐Cause Mortality and Cardiovascular Outcome in Stable Patients—Results From the INTERCATH Cohort(2022)

25 cited

→ The need for PCSK9 inhibitors and associated treatment costs according to the 2019 ESC dyslipidaemia guidelines vs. the risk-based allocation algorithm of the 2017 ESC consensus statement: a simulation study in a contemporary CAD cohort(2020)19 cited

→ Target Populations and Treatment Cost for Bempedoic Acid and PCSK9 Inhibitors: A Simulation Study in a Contemporary CAD Cohort(2021)18 cited

→ Association of high-sensitivity troponin T and I with the severity of stable coronary artery disease in patients with chronic kidney disease(2020)12 cited